Arkolith/Insider Trading/JANX/Form 4

RA Capital Healthcare Fund LP

Director, 10% OwnerJanux Therapeutics, Inc. (JANX) · full profile →Form 4 · filed Mar 7, 2025
Net Buying
Open-Market Buys
$25.3M
Open-Market Sells
$0
Net Open-Market Flow
$25.3M
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 7, 2025Buy(P)110K$31.02$3.4M10.1M
Mar 6, 2025Buy(P)372K$30.78$11.5M10.0M
Mar 5, 2025Buy(P)304K$30.56$9.3M9.6M
Mar 5, 2025Buy(P)37K$31.30$1.2M9.7M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-007443) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML